NBC Cancels Do No Harm

NBC has officially pulled the plug on its medical drama Do No Harm after only two episodes, making it one of the fastest cancellations in recent network history. The decision comes after the show posted historically low ratings, failing to gain traction with viewers despite a high-profile marketing push and a unique premise.

Do No Harm was billed as a modern-day twist on the classic Dr. Jekyll and Mr. Hyde story, centering on neurosurgeon Dr. Jason Cole, played by Steven Pasquale, who struggles to control his dangerous alter ego, Ian Price. The dual-role concept promised psychological tension and moral complexity, but the execution failed to resonate with audiences.

The series debuted to a disappointing 0.9 rating in the key 18–49 demographic, one of the lowest premieres ever for an NBC scripted drama. Its second episode dropped even further, sealing its fate. In a competitive Thursday night slot, Do No Harm simply could not attract the viewership necessary to justify staying on air.

Critics were divided on the series from the outset, with some praising Pasquale’s committed performance while others criticized the uneven writing and lack of suspense. Despite the intriguing concept, the show struggled to balance medical procedural elements with the psychological thriller aspects, leaving many viewers unconvinced.

NBC’s swift decision reflects the current climate of network television, where shows are expected to deliver strong ratings immediately. In a crowded marketplace, even ambitious dramas have little room for error, and Do No Harm became an unfortunate casualty of this reality.

For fans who had begun investing in the story, the cancellation is a disappointment, especially as the series leaves behind unresolved plotlines. However, NBC has not confirmed whether the remaining unaired episodes will be made available online or through a secondary platform.

Industry observers note that Do No Harm joins a long list of high-concept network dramas that failed to survive beyond their initial outings. The series will likely be remembered more for its record-low ratings than for its creative ambition.

Though short-lived, Do No Harm highlights both the challenges and risks of experimenting with genre hybrids on broadcast television. For NBC, the cancellation clears the schedule for more commercially viable programming, while for viewers, it serves as a reminder of the fast-moving nature of modern TV.